­

Welcome to the BNMS Annual Spring Meeting
on 20 - 22 April 2026 in Manchester

Event Symposiums

Register for Event Symposiums here

Curium Pharma UK Ltd symposium

Tuesday 21st April 8 - 8.45am

Location: Exchange 10

Title: Are all 18F labelled PSMA radiopharmaceuticals really the same?

Educational symposium to discuss the challenges of Unspecific Bone Uptake on F-18 PSMA PET scans

Speakers: Dr Dimitrios Moschonas, Consultant Urological Surgeon at Royal Surrey Foundation Hospital and Prof Vineet Prakash, Consultant Nuclear Medicine Physician at Royal Surrey Hospital

curium logo

Bayer-sponsored prostate cancer symposium

Tuesday 21st April 8 - 8.45am

Location: Exchange 9

Title: mCRPC treatment fundamentals and real-world practice with radium-223 dichloride▼

Speakers: Professor Joe O’Sullivan, Clinical Oncologist at The Northern Ireland Cancer Centre and Dr Francis Sundram, Nuclear Medicine Consultant at Southampton General Hospital

This promotional symposium is fully sponsored and organised by Bayer Plc and will include mention of Bayer product. Prescribing Information and Adverse Event Reporting for products mentioned can be found here

This symposium will showcase the overall survival (OS) benefit that Xofigo®▼ (radium-223 dichloride) has in metastatic castration-resistant prostate cancer (mCRPC) patients and demonstrate Xofigo’s use in clinical practice through presentation of case studies. The case studies will illustrate at what point patients should be considered for Xofigo and prior tests that should be done to ensure smooth and timely administration of Xofigo, as well as considerations to ensure 6 cycles of treatment. Case studies will also show how MDT is mobilised to ensure the patient receives timely initiation of Xofigo

Supported with sponsorship from Bayer. Bayer has had no input or involvement in the scientific content, programme design, and speaker selection of the main BNMS conference. Bayer has only been involved in the materials and organisation of the Bayer- sponsored exhibition stand and Bayer-sponsored symposium.

PP-XOF-GB-0753 March 2026

bayer logo

Spectrum Dynamics Symposium

Wednesday 22nd April 8.15 - 9am

Location: Exchange 9

Title: Fully Digital 3D/4D CZT SPECT Imaging – possible, beneficial and realistic for all departments

'VERITON-CT: From Proposal to Pixel'
Nuno Martins, Royal Brompton Hospital, London
The Royal Brompton Hospital journey through planning, purchase, installation and clinical use of a 360° VERITON-CT CZT SPECT/CT scanner. This presentation walks through the business case the strategic, economic, financial, and commercial considerations of the business case; the physical installation project including phased building works; staff training, and the redesign of imaging protocols for dramatically faster scan times and improved image quality.

‘D-SPECT: Ultra-fast MPI Protocols and Dynamic Myocardial Flow Imaging’
Robin McDade, Glasgow Royal Infirmary
How D-SPECT CZT cardiac imaging has transformed the Glasgow Royal Infirmary Nuclear Cardiology service with ultra-fast myocardial perfusion protocols and dynamic flow studies that add additional diagnostic value.

spectrum logo
Register for Event Symposiums here

 

 

© 2013 BNMS unless otherwise stated.
The BNMS is a registered as a company in England and Wales with number 08082786.  The BNMS is a charity governed by the rules of the Charity Commission for England and Wales - Registered Number 1150234.  Registered Office: The Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London NW1 4LE.
The British Nuclear Medicine Society is not able to give specific clinical advice to members of the public. If you are concerned about your scan or therapy please seek the opinion of a nuclear medicine clinician where you were seen or the clinician who referred you to the department or your GP.
Enquiries related to issues such as internships and work experience opportunities, should be directed to the relevant professional body e.g., for radiologists, this will be the Royal College of Radiologists.